Hematologic differences between African-Americans and whites: The roles of iron deficiency and α-thalassemia on hemoglobin levels and mean corpuscular volume

Blood

Volumn 106, Issue 2, 2005, Pages 740-745

  Beutler, Ernest ^a   West, Carol ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; TRANSFERRIN;

ADULT; AFRICAN AMERICAN; AGED; ALPHA THALASSEMIA; ANEMIA; ARTICLE; CAUCASIAN; CREATININE BLOOD LEVEL; ETHNIC GROUP; FEMALE; GENDER; HEMATOCRIT; HEMATOLOGIC DISEASE; HEMOGLOBIN DETERMINATION; HUMAN; IRON DEFICIENCY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; PRIORITY JOURNAL; STANDARD; TRANSFERRIN BLOOD LEVEL;

EID: 22144472981     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2005-02-0713     Document Type: Article

References (31)

1. McLaren CE, Li KT, Gordeuk VR, Hasselblad V, McLaren GD. Relationship between transferrin saturation and iron stores in the African American and US Caucasian populations: analysis of data from the third National Health and Nutrition Examination Survey. Blood. 2001;98:2345-2351.
2. Perry GS, Byers T, Yip R, Margen S. Iron nutrition does not account for the hemoglobin differences between blacks and whites. J Nutr. 1992;122:1417-1424.
3. Beutler E, Barton JC, Felitti VJ, et al. Ferroportin (SCL40A1) variant associated with iron overload in African-Americans. Blood Cells Mol Dis. 2003; 31:305-309.
4. Manolio TA, Burke GL, Savage PJ, et al. Sex- and race-related differences in liver-associated serum chemistry tests in young adults in the CARDIA study. Clin Chem. 1992;38:1853-1859.
5. Reed WW, Diehl LF. Leukopenia, neutropenia, and reduced hemoglobin levels in healthy American blacks. Arch Intern Med. 1991;151:501-505.
6. Johnson-Spear MA, Yip R. Hemoglobin difference between black and white women with comparable iron status: justification for race-specific anemia criteria. Am J Clin Nutr. 1994; 60:117-121.
7. Beutler E, Felitti V, Gelbart T, Ho N. The effect of HFE genotypes in patients attending a health appraisal clinic. Ann Intern Med. 2000;133:329-337.
8. Jackson RT. Separate hemoglobin standards for blacks and whites: a critical review of the case for separate and unequal hemoglobin standards. Med Hypotheses. 1990;32:181-189.
9. Meyers LD, Habicht JP, Johnson CL, Brownie C. Prevalences of anemia and iron deficiency anemia in black and white women in the United States estimated by two methods. Am J Public Health. 1983;73:1042-1049.
10. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of the 845G6A (C282 Y) HFE hereditary haemochromatosis mutation in the USA. Lancet. 2002;359:211-218.
11. Waalen J, Felitti V, Gelbart T, Ho NJ, Beutler E. Prevalence of hemochromatosis-related symptoms in homozygotes for the C282Y mutation of the HFE gene. Mayo Clin Proc. 2002;77:522-530.
12. Oron-Karni V, Filon D, Oppenheim A, Rund D. Rapid detection of the common Mediterranean alpha-globin deletions/rearrangements using PCR. Am J Hematol. 1998;58:306-310.
13. Wittwer CT, Reed GH, Gundry CN, Vandersteen JG, Pryor RJ. High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem. 2003;49:853-860.
14. Pan W-H, Habicht J-P. The non-iron-deficiency-related difference in hemoglobin concentration distribution between blacks and whites and between men and women. Am J Epidemiol. 1991; 134:1410-1416.
15. Yip R, Schwartz S, Deinard AS. Hematocrit values in white, black, and American Indian children with comparable iron status. Am J Dis Child. 1984;138:824-827.
16. Garn SM. Lower hematocrit levels in blacks are not due to diet or socioeconomic factors. Pediatrics. 1981;67:580.
17. Gordeuk V, Mukiibi J, Hasstedt SJ, et al. Iron overload in Africa: interaction between a gene and dietary iron content. N Engl J Med. 1992;326:95-100.
18. Faerstein E, Szklo M, Rosenshein N. Risk factors for uterine leiomyoma: a practice-based case-control study, I: African-American heritage, reproductive history, body size, and smoking. Am J Epidemiol. 2001;153:1-10.
19. Harlow SD, Campbell B. Ethnic differences in the duration and amount of menstrual bleeding during the postmenarcheal period. Am J Epidemiol. 1996;144:980-988.
20. Dozy AM, Kan YW, Embury SH, et al. α-Globin gene organisation in blacks precludes the severe form of α-thalassaemia. Nature. 1979;280:605-607.
21. Pierce HI, Kurachi S, Sofroniadou K, Stamatoyannopoulos G. Frequencies of thalassemia in American blacks. Blood. 1977;49:981-986.
22. Johnson CS, Tegos C, Beutler E. Alpha-thalassemia: prevalence and hematologic findings in American blacks. Arch Intern Med. 1982;142:1280-1282.
23. Higgs DR, Bowden DK. Clinical and laboratory features of the α-thalassemla syndromes. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, eds. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. Cambridge, UK: Cambridge University Press; 2001:431-469.
24. Higgs DR, Pressley L, Clegg JB, et al. Detection of alpha thalassaemia in negro infants. Br J Haematol. 1980;46:39-46.
25. Rana SR, Sekhsaria S, Castro OL. Hemoglobin S and C traits: contributing causes for decreased mean hematocrit in African-American children. Pediatrics. 1993;91:800-802.
26. Yip R, Nelson PE. Hemoglobin concentration of children with sickle cell trait. J Pediatr. 1981;99:257-258.
27. Serjeant GR, Serjeant BE, Forbes M, Hayes RJ, Higgs DR, Lehmann H. Haemoglobin gene frequencies in the Jamaican population: a study in 100,000 newborns. Br J Haematol. 1986;64:253-262.
28. Sylvester-Jackson DA, Page SL, White JM, et al. Unbiased analysis of the frequency of beta-thalassemia point mutations in a population of African-American newborns. Arch Pathol Lab Med. 1993;117:1110-1114.
29. Brewer GJ. Genetic and population studies of quantitative levels of adenosine triphosphate in human erythrocytes. Biochem Genet. 1967;1:25-34.
30. Wallas CH. Elevated red blood cell 2,3-diphosphoglycerate levels in black blood donors. Transfusion. 1978;18:108-112.
31. Hershman D, Weinberg M, Rosner Z, et al. Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. JNCI. 2003;95:1545-1548.